• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光化性角化病治疗后美容效果的专家共识

Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis.

作者信息

Berman Brian, Ablon Glynis R, Bhatia Neal D, Ceilley Roger I, Goldberg David J, Nestor Mark S, Weinkle Susan H

出版信息

J Drugs Dermatol. 2017 Mar 1;16(3):260-264.

PMID:28301622
Abstract

Dermatologists treat actinic keratosis (AK) primarily because these lesions have the potential to progress to invasive squamous cell carcinoma. Patients, on the other hand, generally seek treatment to remove the lesions and achieve an improved appearance of their skin following treatment. In selecting a treatment option for AK, dermatologists should consider post-treatment cosmesis, because cosmetic outcomes differ across AK treatments. To obtain expert opinion on the cosmetic sequelae related to chronically photodamaged skin and the treatment of AK, an expert panel meeting among dermatologists was conducted in February 2016. These experts reviewed current treatment options for photodamage, including AK, and discussed the relative merits of the various cosmetic assessments commonly used by investigators and patients in both clinical trial and dermatology practice settings. A main goal of the expert panel meeting was to propose assessment tools that could be specifically designed to characterize cosmesis results after treatment of AK. The panel agreed that existing tools for measurement of cosmetic outcomes following treatment of photodamage could also be used to evaluate cosmesis after treatment of AK. Digital photography is probably the best method used for this, with validation by other technologies. Better measurement tools specifically for assessing cosmesis after AK treatment are needed. Once they are developed and validated, regulatory agencies should be educated about the importance of including cosmetic outcomes as a component of product labeling.

J Drugs Dermatol. 2017;16(3):260-265.

.
摘要

皮肤科医生治疗光化性角化病(AK)主要是因为这些病变有可能发展为浸润性鳞状细胞癌。另一方面,患者通常寻求治疗以去除病变并在治疗后改善皮肤外观。在选择AK的治疗方案时,皮肤科医生应考虑治疗后的美容效果,因为不同的AK治疗方法其美容效果有所不同。为了获取关于慢性光损伤皮肤相关的美容后遗症以及AK治疗的专家意见,2016年2月组织了一场皮肤科医生专家小组会议。这些专家回顾了包括AK在内的光损伤的当前治疗方案,并讨论了研究者和患者在临床试验及皮肤科实践环境中常用的各种美容评估方法的相对优点。专家小组会议的一个主要目标是提出能够专门设计用于描述AK治疗后美容效果的评估工具。该小组一致认为,现有的用于测量光损伤治疗后美容效果的工具也可用于评估AK治疗后的美容效果。数字摄影可能是用于此目的的最佳方法,并需通过其他技术进行验证。需要更好的专门用于评估AK治疗后美容效果的测量工具。一旦开发并验证了这些工具,应让监管机构了解将美容效果作为产品标签组成部分的重要性。

《皮肤用药杂志》。2017年;16(3):260 - 265。

相似文献

1
Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis.光化性角化病治疗后美容效果的专家共识
J Drugs Dermatol. 2017 Mar 1;16(3):260-264.
2
Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.意大利医生对光化性角化病管理的意见和临床实践模式。
G Ital Dermatol Venereol. 2014 Apr;149(2):185-92.
3
Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.优化光化性角化病和光损伤皮肤的管理:采用逐步方法。
Cutis. 2009 Sep;84(3):169-75.
4
Insight into the management of actinic keratosis: a qualitative interview study among general practitioners and dermatologists.光化性角化病管理的洞察:全科医生和皮肤科医生的定性访谈研究。
Br J Dermatol. 2019 Jul;181(1):96-104. doi: 10.1111/bjd.17818. Epub 2019 Mar 15.
5
Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.光化性角化病:丹麦皮肤科诊所疾病特征与治疗模式的横断面研究
Int J Dermatol. 2016 Mar;55(3):309-16. doi: 10.1111/ijd.12874. Epub 2015 Aug 14.
6
A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity.一种用于评估光化性角化病疾病严重程度分级的新型光化性角化病皮损评估量表。
Acta Derm Venereol. 2017 Oct 2;97(9):1108-1113. doi: 10.2340/00015555-2710.
7
Emerging drugs for actinic keratosis.光化性角化病的新兴药物。
Expert Opin Emerg Drugs. 2010 Dec;15(4):545-55. doi: 10.1517/14728214.2010.507191. Epub 2010 Jul 29.
8
Sequential Treatment of Actinic Keratosis and Photoaging by Daylight PDT and Injectable NASHA Gel as Skin Booster.日光光动力疗法联合注射型 NASHA 凝胶作为皮肤增强剂序贯治疗光化性角化病和皮肤光老化。
J Drugs Dermatol. 2020 Nov 1;19(11):1065-1068. doi: 10.36849/JDD.2020.2229.
9
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.澳大利亚关于使用含甲基氨基乙酰丙酸乳膏的日光光动力疗法治疗光化性角化病的共识性建议。
Australas J Dermatol. 2016 Aug;57(3):167-74. doi: 10.1111/ajd.12354. Epub 2015 May 31.
10
Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations.拉丁美洲日光介导的光动力疗法治疗光化性损伤:共识推荐
Photodermatol Photoimmunol Photomed. 2016 Mar;32(2):81-7. doi: 10.1111/phpp.12221. Epub 2015 Dec 9.

引用本文的文献

1
Phototherapy as a Treatment for Dermatological Diseases, Cancer, Aesthetic Dermatologic Conditions and Allergenic Rhinitis in Adult and Paediatric Medicine.光疗在成人和儿童医学中作为治疗皮肤病、癌症、美容皮肤病及变应性鼻炎的方法
Life (Basel). 2023 Jan 9;13(1):196. doi: 10.3390/life13010196.
2
Phototherapy with Light Emitting Diodes: Treating a Broad Range of Medical and Aesthetic Conditions in Dermatology.发光二极管光疗法:治疗皮肤科广泛的医学和美容病症
J Clin Aesthet Dermatol. 2018 Feb;11(2):21-27. Epub 2018 Feb 1.